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Abstract
Background: Joint, spinal and soft tissue injections are commonly performed by rheumatologists in their daily
practice. Contrary to other procedures, e.g. performed in pediatric care, little is known about the frequency, the
intensity and the management of procedural pain observed in osteo-articular injections in daily practice.
Methods: This observational, prospective, national study was carried out among a French national representative
database of primary rheumatologists to evaluate the prevalence and intensity of pain caused by intra-and peri-
articular injections, synovial fluid aspirations, soft tissue injections, and spinal injections. For each physician, data
were collected over 1 month, for up to 40 consecutive patients (>18-years-old) for whom a synovial fluid
aspiration, an intra or peri-articular injection or a spinal injection were carried out during consultations. Statistical
analysis was carried out in order to compare patients who had suffered from pain whilst undergoing the
procedure to those who had not. Explanatory analyses were conducted by stepwise logistic regression with the
characteristics of the patients to explain the existence of pain.
Results: Data were analysed for 8446 patients (64% female, mean age 62 ± 14 years) recruited by 240 physicians.
The predominant sites injected were the knee (45.5%) and spine (19.1%). Over 80% of patients experienced
procedural pain which was most common in the small joints (42%) and spine (32%) Pain was severe in 5.3% of
patients, moderate in 26.6%, mild in 49.8%, and absent in 18.3%. Pain was significantly more intense in patients
with severe pain linked to their underlying pathology and for procedures performed in small joints.
Preventative or post-procedure analgesia was rarely given, only to 5.7% and 36.3% of patients, respectively. Preven-
tative analgesia was more frequently prescribed in patients with more severe procedural pain.
Conclusion: Most patients undergoing intra-or peri-articular injections, synovial fluid aspirations and spine injections
suffer from procedural pain. Most patients experience usually mild procedural pain and procedural pain management is
uncommonly provided by physicians. Specific research and guidelines for the management of procedural pain related
to rheumatologic care should be established to improve the quality of care provided by physicians.
Background
Patients undergoing physical examination, diagnostic
and therapeutic interventions are often subject to pain
as a result of their medical care. Despite this, nearly
two-thirds of patients undergoing potentially painful
medical procedures do not receive any form of analgesia
[1]. Management of care-related pain is now a priority
in paediatric care where lots of review and guidelines
have been published [2] but remains poorly studied in
adults, and particularly in rheumatological practice.
Pain induced by medical procedures i.e. “procedural
pain” has largely been studied in paediatric populations
[3,4] and, with the exception of pain linked to a few speci-
fic procedures such as turning, drain removal and catheter
insertion [5-8], there is little information concerning pro-
cedural pain in adults. A few studies have investigated pro-
cedural pain in surgical or oncology patients [9-12], but
there are no data concerning the intensity or frequency of
pain induced by medical procedures in rheumatological
conditions. Invasive proced u r e ss u c ha sp u n c t u r e sa n d
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any medium, provided the original work is properly cited.infiltrations are carried out routinely in the diagnosis and
therapy of musculoskeletal disorders, not only by rheuma-
tologists, but also by family physician [13]. However, it has
not been determined whether these procedures are painful
to patients. Although Wang et al. reported that injection
of corticosteroids into the elbow did not increase pain
these authors did not investigate specifically pain induced
by the procedure itself [14].
Since invasive procedures such as corticosteroid injec-
tions, anaesthetic injections, and dry needling are carried
out frequently in rheumatology [15,16], it is important
to better understand which factors influence procedural
pain, and how it can be managed effectively. Some pro-
cedures for the management of induced pain have been
established in rheumatology department, but not vali-
dated and published, and most approaches to date have
used empirical treatment. The results of studies on the
use of topical lidocaine-prilocaine cream (EMLA) before
vascular puncture and corticosteroid injections are con-
tradictory [17-19]. It therefore seemed pertinent to eval-
uate pain linked to different procedures in
rheumatology, and how this pain is currently managed.
This national observational prospective study was set
up to evaluate the frequency of puncture and/or infiltra-
tion-induced pain in rheumatological practice, and the
different preventative and post-procedure therapeutic
approaches currently used to manage procedural pain.
Methods
Study design
This was an epidemiological observational, cross-sec-
tional, national study carried out among French rheu-
matologists between 2006 and 2007, after obtaining
approval of french national ethical committee
(CCTIRS). Each participating rheumatologist was asked
to record data for all consecutive adult patients who
underwent a diagnostic or therapeutic procedure (punc-
ture, or infiltration, or both) at the time of consultation,
irrespective of localisation. The observation period
extended over 1 month of visits.
Selection of rheumatologists
Rheumatologists were selected from the French rheuma-
tologist’ representative TVF database (source CEGEDIM
group). In order to guarantee a high level of respon-
dents, details of the study and a request to participate
were sent out to all rheumatologists across France in
two mail-shots. This enabled some adjustment in the
second mailing according to the level and regionality of
the response to the first. The rheumatologists in the
first mail-shot were chosen by drawing lots stratified
according to administrative region.
T h ee x p e r i e n c eo fe a c hr h e u m a t o l o g i s tw a sd e t e r -
mined indirectly from their age, assuming that they had
started practising professionally when they were 27-
years-old. The study was proposed to 1800 French rheu-
matologists with private practice. After 2 contacts and
propositions, 339 rheumatologists accepted to partici-
pate. Finally, of these 339 rheumatologists, only 252
rheumatologists have participated actively in the study
and have recruited patients. The demographics of these
rheumatologists were compared to the global demo-
graphics of French rheumatologists and did not demon-
strate significant difference, according to age, sex-ratio,
number of years of practicing, location.
Patient selection
All consecutive adult patients (>18 years of age) suffering
from a non-malignant musculoskeletal pathology for
which a diagnostic and/or therapeutic procedure (punc-
ture, or infiltration, or both) was carried out at the time of
consultation were recruited (maximum of 40 patients per
rheumatologist). As this was an observational study, the
only exclusion criteria were mesotherapy or acupuncture
procedures. All patients provided informed consent before
procedure.
Data collection
The following data were recorded for each patient: age;
sex; underlying pathology for which the procedure was
required; previous experience of the patient regarding a
similar type of procedure; details of the procedure [20]
performed (type, localisation, aim, planned or not);
analgesic protocols (preventative, post-procedure)
used; evaluation of pain before procedure and
during procedure, and of the patients’ experience post-
procedure.
Evaluation of pain intensity
Pain intensity was evaluated using verbal scale (none,
mild, moderate or severe). The verbal rating scale is a
commonly used scale, easier to understand than Visual
Analog Scale. It has been validated in many studies and
is one of the three most commonly used scale [21].
Patient’s pain intensity was assessed immediately
before the procedure, considering mean pain intensity
during the previous week before procedure. Then, after
the procedure, patients had to report to the physician
their level of pain induced by the procedure,.
Primary evaluation criteria
The primary objectives of the study were to evaluate: (i)
the respective frequency of different articular and peri-
articula
r procedures in rheumatological primary practice; (ii)
the frequency and intensity of pain linked to these dif-
ferent procedures; (iii) the demographic factors for pro-
cedural pain. (iv) the type and frequency of analgesic
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tered for procedural pain;
Statistical analysis
Statistical analysis was carried out in order to compare
patients who had suffered from pain whilst undergoing
the procedure to those who had not. Explanatory ana-
lyses were conducted with the characteristics of the
patients to explain the existence of pain. When patients
had more than one procedure during the visit, each pro-
cedure was assessed separately.
For descriptive data, quantitative variables are pre-
sented as number (n), means and standard deviation
(SD), and qualitative variables as n and % of available
data. For the descriptive and univariate analysis, quanti-
tative variables were analysed using the Wilcoxon or
Mann-Whitney test, and qualitative variables were com-
pared using the Chi
2-Pearson or Fisher’se x a c tt e s t .T h e
level of significance selected was 0.05.
Multivariate analysis was carried out by stepwise logis-
tic regression with the dependent variable being the pre-
sence or absence of pain. Significant factors to the
threshold of 20% in univariate analysis were included in
multivariate analysis. Entry threshold was set-up at 10%
and conservation threshold to 15%.
Statistical analysis was carried out using SAS® (version
8.2; SAS Institute, North Carolina, USA).
Results
Rheumatologists
A total of 240 French rheumatologists took part in this
study (57.7% male, mean age 49 years). 68.1% had exclu-
sive private practice, 31.4% had a mixed hospital/surgery
practice and the rest were practicing exclusively in hos-
pital. The rheumatologists each had an average of 22
years experience.
Patient characteristics
Data were analysed for 8446 patients who underwent a
puncture, or infiltration, or both, during visit to 240
rheumatologists across France. The mean age of the
patients was 62 ± 14 years and the majority were female
(64.4%). The demographic characteristics of the patients
are summarised in Table 1.
In 31.3% of the cases patients had joint osteoarthritis,
tendonitis in 18.1%, radiculalgia in 9.1%, back pain in
7.2%, inflammatory rheumatological disorder in 3.8%
(mostly rheumatoid arthritis), and a tunnel syndrome in
4.4%. In 66.8% of the cases, patients were prescribed
analgesics for the pain related to the underlying pathology.
Types of procedure performed
In total, 91.8% of patients underwent only one proce-
dure. The knee was the main site of intervention
(45.4%), followed by spine (19.1%), shoulder (15.0%) and
small joints (12.0%). The procedure was unilateral in
91.6% of patients, intra-articular in 57.0%.
The procedure was carried out for therapeutic pur-
poses in the majority of patients (91.8%), and was diag-
nostic and therapeutic in 6.8%. Over half of the patients
(56.1%) were given a corticosteroid injection, while
26.0% received an injection of hyaluronic acid. In the
remaining cases, procedure was a synovial fluid aspira-
tion or combination of aspiration and injections
(Table 2). Approximately half (53.9%) of the interven-
tions were planned before the consultation.
Incidence of procedural pain
The majority of patients (81.7%) experienced some
degree of pain induced by the procedure. Pain was con-
s i d e r e dt ob es e v e r eb y5 . 3 %o fp a t i e n t s ,m o d e r a t eb y
2 6 . 6 % ,a n dm i l db y4 9 . 8 % .As m a l lp r o p o r t i o no f
patients (18.3%) experienced no pain (Figure 1).
Table 1 Demographic and clinical characteristics of the patients.
(n = 8446)
Age (mean ± SD), years 62 ± 14
<50 1613 (19.2%)
50-59 1860 (22.0%)
60-69 1945 (23.1%)
70-79 2050 (24.3%)
≥80 970 (11.5%)
Sex (female/male), % 64/36
Number of patients taking analgesic medication for their underlying pathology during the previous week 5643 (67%)
Pain linked to the underlying pathology during the previous week (n = 8434) no pain, n (%) 78 (0.9%)
mild pain, n (%) 1179 (14.0%)
moderate pain, n (%) 4067 (48.2%)
severe pain, n (%) 3110 (36.9%)
*Data missing for some patients.
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Univariate analysis demonstrated that the intensity of
pain varied significantly associated with the site of the
injection/aspiration. Pain was considered to be more
intense (moderate to severe) in 41% of cases involving
the small joints, 32% involving the head and spine, 30%
for the shoulders and 28% for the knees (Figure 2).
Other factors like age (p < 0.001), sex of the patient
(p < 0.001), type of underlying rheumatological pathol-
ogy (p < 0.001), pain in the previous week related to
this underlying pathology (p < 0.001), analgesic treat-
ment for pain related to this underlying pathology
(p < 0.001), procedure planned before the visit
(p = 0.001) and patient’s procedural perception evalu-
ated by the physician (p < 0.001) were significant factors
associated with procedural pain.
On the contrary, univariate analysis demonstrated that
actual flare of the disease, history of previous procedure,
number of procedures performed on the same visit,
body-side of the procedure, type of injection (intra vs
extra-articular), aim of the procedure (therapeutic vs
diagnostic procedure) were not significant factors for
the occurrence of procedural pain.
From this univariate analysis, fourteen demographic
and pain ratings explanatory variables linked to the
occurrence of pain during the procedure (with signifi-
cant threshold of 20% in univariate analysis) were
included in the multivariate analysis (Table 3). It
demonstrated significant differences for intensity of
pain linked to the underlying pathology during the
week preceding the procedure (p < 0.0001), site on
which the intervention was required (p = 0.0006) and
the patient’s procedural perception evaluated by the
physician (p < 0.0001). Thus, pain was considered to
be significantly and independently more intense in
patients with more severe pain linked to their underly-
ing pathology, for procedures performed in small
joints, globally in accordance with the perception of
the procedure by the rheumatologists. There was a
trend towards more intense pain in women, but not
significant. The use of preventative analgesic protocol
was also significantly associated with the presence of
procedural pain in univariate analysis (p = 0.005),
demonstrating that physicians were taking into account
the possibility of that induced pain.
Perception of rheumatologists regarding procedural pain
experienced by their patients
On the whole, rheumatologists thought that the major-
ity of their patients had tolerated the procedure very
( 5 3 . 1 % )o rq u i t e( 3 9 . 8 % )w e l l ,a n dt h a to n l y
0.7% of patients had suffered badly during the proce-
dure (Figure 3). This was in accordance with the inten-
sity of pain experienced during the procedure by their
patients (kappa score: 0.44).
Management of procedural pain
Less than half of the patients received any analgesia
(either preventative or curative) for their pain. Only
5.7% of patients were given preventative analgesic medi-
cation, usually local anaesthesia (34.8%), xylocaïne
patches (20.5%), acetaminophen alone (14.3%; Step 1
analgesics I) and Step 2 analgesics (11.2%). In most
patients this was initiated by the physician (82.6% of
cases) rather than at the request of the patient. The
mean duration between receiving preventative analgesia
and the procedure was 38 ± 74 min. There was no sig-
nificant difference in the use of preventative analgesia
between patients undergoing a single procedure and
those undergoing two (p = 0.683).
Post-procedure analgesia was given to 36.3% of
patients and was initiated by the physician in 94.6% of
the cases. The most common analgesics prescribed
were step 2 analgesics (weak opioids combined to acet-
aminophen) (35.8%), non-steroidal anti-inflammatory
drugs (NSAIDs) (34.8%) and acetaminophen alone
(34.2%).
Discussion
This research highlights a major problem in rheuma-
tology care. Pain caused by injections and aspirations
from the joints is a common occurrence for patients,
in 81.7% of the cases and may represent a significant
medical stressor. The large sample size of our study
Figure 1 Global pain intensity linked to all the procedures
performed (n = 8393).
Table 2 Type of procedure performed during the visit
n = 8123
Steroid injection 4557 (56.1%)
Hyaluronic acid injection 2108 (26.0%)
Joint aspiration and steroid injection 555 (6.8%)
Steroid and analgesic drug injection 271 (3.3%)
Joint aspiration and hyaluronic acid injection 223 (2.8%)
Joint aspiration alone 133 (1.6%)
Other procedures 276 (3.4%)
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health significance of the problem. These results imply
that more should be done to manage the pain caused
by procedures to relieve suffering and functional
impairments in osteo-articular pathological conditions.
Procedural pain has been investigated previously in a
number of hospital populations [1-4,6-13,22], mostly in
cancer management, but never in patients with painful
musculoskeletal conditions, in rheumatological
practice.
Our observational study shows that the procedural
pain can be moderate to severe in intensity in approxi-
mately one-third (31.9%) of patients, particularly if the
procedure involves the small joints. Preventative and
post-procedural pain management, both by pharmacolo-
gical and non-pharmacological approaches should be
performed specifically in these situations. There is also
evidence that pain is more intense in patients with
severe pain linked to their underlying pathology, and
this also suggests that better pain control of the under-
lying pathology may decrease the discomfort related to
the procedure.
Local infiltration therapies including corticosteroid
injections are commonly used in the management of
musculoskeletal disorders and have been shown to bring
about short-term pain relief in a number of conditions
including osteoarthritis, inflammatory arthritis, synovitis,
tendonitis and bursitis [23,24]. In the current study,
over half of our patients received a corticosteroid injec-
tion during the visit and a further 25% received an injec-
tion of hyaluronic acid. While it was previously reported
that the injection of corticosteroids into the elbow did
not increase pain linked to the underlying pathology
[14], we have demonstrated that infiltrations themselves
can be extremely painful in some people. Many medical
and non-medical staff constantly under-estimate pain in
their patients [23], or are unaware that some medical
procedures can cause pain [22]. This is borne out by the
results of a study by Puntillo et al. where almost two-
thirds of patients undergoing six specific medical proce-
dures did not receive any analgesic or opiate medication
[1] and this in part explains their reluctance to prescribe
preventative analgesic medication. Several studies have
reported that vascular procedures, including venipunc-
ture and arterial puncture, are a significant cause of
pain, and there is some evidence that application of
anaesthetic lidocaine-prilocaine cream (EMLA) to the
puncture site before the procedure can successfully pre-
vent pain [18,19]. Despite evidence of efficacy however,
local anaesthetic creams are still rarely used routinely in
hospitals [3,9]. However, perception by rheumatologists
of the conditions of the procedure was well correlated
with the occurrence of procedure-related pain, and with
the prescription of preventative analgesia, even if this
doesn’t demonstrate a real efficacy to prevent proce-
dure-related pain.
T h er e s u l t so ft h i ss t u d ya r es u b j e c tt os o m el i m i t a -
tions. Recruitment bias was overcome by selecting rheu-
matologists from a national list. Self-selection bias of
patients is difficult to determine because the number
and characteristics of non-volunteers were not assessed:
rheumatologists were invited to include all consecutive
patients, within a month, that needed joint procedure.
Since this was an observational study, and because we
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Figure 2 Intensity of procedural pain according to site of intervention (n = 8372): percentage of each verbal rating category for each
procedure site.
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the protocol for participating rheumatologists, we did
not ask rheumatologists to assess patients who do not
accept to participate in the study. Also for practical rea-
sons and to raise the number of physicians and patients
involved, we have used the more simple method to
assess pain, a categorical verbal rating, that is a validated
but a less accurate method than pain Visual Analog
Scale (VAS) or pain Numerical Rating Scale (NRS). It is
obvious that a pain VAS would have been an improve-
ment. The study highlighted some demographic corre-
lates of pain but it did not include any psychological or
behavioral variables, as anxiety or fear of the procedure,
that could be interesting data to analyse. Another limita-
tion of our study is that we did not differentiate the
devices used by the physicians. Several authors have
e m p h a s i z e dt h ef a c tt h a ts i z eo ft h es y r i n g ea n dn e e d l e
may influence pain and tissue trauma during procedure.
Recent findings have also pointed out the usefulness of
sonographic-guided injections to improve the quality of
care in rheumatological procedures [25]. The last limita-
tion concerning our study is that we did not precisely
assess the levels of experience of the recruiting physi-
cians, as physician training and number of injections
performed regularly are important factors that may
influence physicians confidence and quality of care [26].
Table 3 Multivariate analysis of existence of pain versus no pain after the procedure
Explanatory variables OR * 95% CI P-value**
Patient perception of the procedure assessed by the physician < 0.0001
Very/Quite badly
R 1
Quite well 0.271 [0.085 - 0.865] (S)
Very well 0.013 [0.004 - 0.041] (S)
Pain intensity related to underlying pathology in the previous week
Absent
R 1 < 0.0001
Mild 1.348 [0.780 - 2.330] (NS)
Moderate 1.780 [1.039 - 3.051] (S)
Severe 2.024 [1.165 - 3.513] (S)
Underlying pathology 0.0006
Acute
R 1
Chronic 1.725 [1.099 - 2.708] (S)
Inflammatory rheumatological disorder 2.521 [1.474 - 4.310] (S)
Joint osteoarthritis 2.302 [1.548 - 3.423] (S)
Flare-up over degenerative pathology 1.972 [1.301 - 2.988] (S)
Post-traumatic 2.967 [1.483 - 5.935] (S)
Back pain 1.755 [1.077 - 2.861] (S)
Radiculalgia 1.394 [0.856 - 2.272] (NS)
Tunnel syndrome 1.975 [1.148 - 3.399] (S)
Tendonitis 1.310 [0.876 - 1.960] (NS)
Bursitis 1.241 [0.716 - 2.151] (NS)
Cristal arthropathy 1.883 [0.772 - 4.595] (NS)
Sex
Male
R 1 0.0557
Female 1.141 [0.998 - 1.304] (NS)
Site of procedure
Knee
R 1 0.0889
Spine 1.160 [0.854 - 1.576] (NS)
Shoulder 1.174 [0.901 - 1.530] (NS)
Small joints 1.551 [1.137 - 2.118] (S)
Others 1.212 [0.903 - 1.627] (NS)
Multivariate analysis was carried out with variables selected from univariate analysis that demonstrated a significant threshold of 20%.
Multivariate analysis was performed on 7518/8446 patients. 928 observations were not included due to missing data.
*OR: Odds-Ratio
CI: Confident Interval
** Chi
2 test significance
S: significant CI
NS: non significant
R: Reference.
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gists, with a mean experience in joint and soft tissue
injections of 22 years.
Conclusion
It is important to make rheumatologists more aware
that patients may find infiltrations and/or joint aspira-
tion painful so that specific analgesic protocols can be
implemented. In this study, analgesia was usually
initiated by the rheumatologist rather than at the
request of the patient. Thus, physicians have a pivotal
role to play in the management of pain linked to mus-
culoskeletal disorders and to any interventional proce-
dures performed. Greater prescription of preventative
and post-procedural analgesic procedures (both pharma-
cological and non-pharmacological) should be encour-
aged in order to improve the quality of care offered by
rheumatologists.
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